Insulin treatment did not alter GnRH-induced increases in circulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in either control or PCOS-like monkeys in comparison to diluent treatment at 4–6 months following treatment onset. The gene discussed is BRD2; the disease is polycystic ovary syndrome.